08:00 , Feb 27, 2012 |  BC Week In Review  |  Company News

Bioheart, Ageless Regenerative Institute deal

The institute granted Bioheart exclusive, worldwide rights to LipiCell adipose-derived stem cell technology to treat heart attack and heart failure. The institute will receive an upfront payment and milestones. Bioheart is conducting a Phase...